Metabolic Enzymes Moonlighting in the Nucleus: Metabolic Regulation of Gene Transcription

Trends in Biochemical Sciences

Volumn 41, Issue 8, 2016, Pages 712-730

  Boukouris, Aristeidis E ^a   Zervopoulos, Sotirios D ^a   Michelakis, Evangelos D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

epigenetic regulation; fuel and nutrient sensing; metabolic enzymes; nuclear translocation

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ACETYL COENZYME A; ACONITATE HYDRATASE; ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; FUMARATE HYDRATASE; GLUCOSE 6 PHOSPHATE ISOMERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE; ISOCITRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; MALATE DEHYDROGENASE; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE; SUCCINATE DEHYDROGENASE;

ADAPTIVE BEHAVIOR; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL METABOLISM; CELL MIGRATION; CELL PROLIFERATION; CITRIC ACID CYCLE; ENZYME METABOLISM; EPIGENETICS; GENE PRODUCT; GLYCOLYSIS; HISTONE ACETYLATION; HISTONE METHYLATION; HOMEOSTASIS; HUMAN; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; TRANSCRIPTION REGULATION; CELL NUCLEUS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; L-LACTATE DEHYDROGENASE; TRANSCRIPTION, GENETIC;

EID: 84992579961     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2016.05.013     Document Type: Review

References (134)

1. 1 Hendriks, W., et al. Duck lens epsilon-crystallin and lactate dehydrogenase B4 are identical: a single-copy gene product with two distinct functions. Proc. Natl. Acad. Sci. U.S.A. 85 (1988), 7114–7118.
2. 2 Huberts, D.H., van der Klei, I.J., Moonlighting proteins: an intriguing mode of multitasking. Biochim. Biophys. Acta. 1803 (2010), 520–525.
3. 3 Kaelin, W.G. Jr, McKnight, S.L., Influence of metabolism on epigenetics and disease. Cell 153 (2013), 56–69.
4. 4 Nelson, D.L., Cox, M.M., Lehninger: Principles of Biochemistry. 2013, W.H. Freeman and Company.
5. 5 Sutendra, G., et al. A nuclear pyruvate dehydrogenase complex is important for the generation of acetyl-CoA and histone acetylation. Cell 158 (2014), 84–97.
6. 6 Matsuda, S., et al. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor. Nucleic Acids Res. 44 (2015), 636–647.
7. 7 Yang, W., et al. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150 (2012), 685–696.
8. 8 McEwen, B.S., et al. Studies on energy-yielding reactions in thymus nuclei. III. Participation of glycolysis and the citric acid cycle in nuclear adenosine triphosphate synthesis. J. Biol. Chem. 238 (1963), 2579–2586.
9. 9 Siebert, G., Bestimmung von Glykolyse-Metaboliten in isolierten Zellkernen. Experientia, 14, 1958, 449.
10. 10 Siebert, G., Humphrey, G.B., Enzymology of the nucleus. Adv. Enzymol. Relat. Areas Mol. Biol. 27 (1965), 239–288.
11. 11 Kim, J.W., Dang, C.V., Multifaceted roles of glycolytic enzymes. Trends Biochem. Sci. 30 (2005), 142–150.
12. 12 Konings, A.W., Glucose oxidation in nuclei isolated from frat thymus. Life Sci. 8 (1969), 1009–1016.
13. 13 Konings, A.W., On the dependence of nuclear oxidative phosphorylation on glycolysis in isolated rat thymus nuclei. Experientia 25 (1969), 809–811.
14. 14 Guillemain, G., et al. The large intracytoplasmic loop of the glucose transporter GLUT2 is involved in glucose signaling in hepatic cells. J. Cell Sci. 113 (2000), 841–847.
15. 15 Pantaleon, M., et al. An unusual subcellular localization of GLUT1 and link with metabolism in oocytes and preimplantation mouse embryos. Biol. Reprod. 64 (2001), 1247–1254.
16. + and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc. Natl. Acad. Sci. U.S.A. 100 (2003), 9202–9207.
17. 17 Rutter, J., et al. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science 293 (2001), 510–514.
18. 18 Allfrey, V.G., Mirsky, A.E., The role of ceoxyribonucleic acid and other polynucleotides in ATP synthesis by isolated cell nuclei. Proc. Natl. Acad. Sci. U.S.A. 43 (1957), 589–598.
19. 19 Wright, R.H.G., et al. ADP-ribose derived nuclear ATP is required for chromatin remodeling and hormonal gene regulation. bioRxiv, 2014, 10.1101/006593 Published online June 25, 2014.
20. 20 Wolf, Y.I., et al. The universal distribution of evolutionary rates of genes and distinct characteristics of eukaryotic genes of different apparent ages. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 7273–7280.
21. 21 Wilson, J.E., Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J. Exp. Biol. 206 (2003), 2049–2057.
22. 22 Brown, K.S., et al. Glucokinase regulatory protein may interact with glucokinase in the hepatocyte nucleus. Diabetes 46 (1997), 179–186.
23. 23 Neary, C.L., Pastorino, J.G., Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells. J. Cell. Physiol. 228 (2013), 1943–1948.
24. 24 Neary, C.L., Pastorino, J.G., Nucleocytoplasmic shuttling of hexokinase II in a cancer cell. Biochem. Biophys. Res. Commun. 394 (2010), 1075–1081.
25. 25 Gancedo, J.M., Yeast carbon catabolite repression. Microbiol. Mol. Biol. Rev. 62 (1998), 334–361.
26. 26 Funasaka, T., et al. Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia. FASEB J. 19 (2005), 1422–1430.
27. 27 Watanabe, H., et al. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res. 56 (1996), 2960–2963.
28. 28 Enzo, E., et al. Aerobic glycolysis tunes YAP/TAZ transcriptional activity. EMBO J. 34 (2015), 1349–1370.
29. 29 Yalcin, A., et al. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J. Biol. Chem. 284 (2009), 24223–24232.
30. 30 Mor, I., et al. Control of glycolysis through regulation of PFK1: old friends and recent additions. Cold Spring Harb. Symp. Quant. Biol. 76 (2011), 211–216.
31. 31 Ciesla, M., et al. Fructose bisphosphate aldolase is involved in the control of RNA polymerase III-directed transcription. Biochim. Biophys. Acta 1843 (2014), 1103–1110.
32. 32 Ronai, Z., et al. Aldolase–DNA interactions in a SEWA cell system. Biochim. Biophys. Acta 1130 (1992), 20–28.
33. 33 Saez, D.E., Slebe, J.C., Subcellular localization of aldolase B. J. Cell. Biochem. 78 (2000), 62–72.
34. 34 Mamczur, P., et al. Nuclear localization of aldolase A correlates with cell proliferation. Biochim. Biophys. Acta 1833 (2013), 2812–2822.
35. 35 Li, B., et al. Fructose-1,6-bisphosphatase opposes renal carcinoma progression. Nature 513 (2014), 251–255.
36. 36 Hara, M.R., et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat. Cell Biol. 7 (2005), 665–674.
37. 37 Kanwar, M., Kowluru, R.A., Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic retinopathy. Diabetes 58 (2009), 227–234.
38. 38 Yego, E.C., Mohr, S., Siah-1 Protein is necessary for high glucose-induced glyceraldehyde-3-phosphate dehydrogenase nuclear accumulation and cell death in Muller cells. J. Biol. Chem. 285 (2010), 3181–3190.
39. 39 Zheng, L., et al. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell 114 (2003), 255–266.
40. 40 Sundararaj, K.P., et al. Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 279 (2004), 6152–6162.
41. 41 Kumble, K.D., Vishwanatha, J.K., Immunoelectron microscopic analysis of the intracellular distribution of primer recognition proteins, annexin 2 and phosphoglycerate kinase, in normal and transformed cells. J. Cell. Sci. 99 (1991), 751–758.
42. 42 Popanda, O., et al. Modulation of DNA polymerases alpha, delta and epsilon by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim. Biophys. Acta 1397 (1998), 102–117.
43. 43 Egea, G., et al. Nuclear location of phosphoglycerate mutase BB isozyme in rat tissues. Histochemistry 97 (1992), 269–275.
44. 44 Qiu, H., et al. Assignment and expression patterns of porcine muscle-specific isoform of phosphoglycerate mutase gene. J. Genet. Genomics 35 (2008), 257–260.
45. 45 Wang, W., et al. Identification of alpha-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex. J. Endocrinol. 184 (2005), 85–94.
46. 46 Feo, S., et al. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 473 (2000), 47–52.
47. 47 Hsu, K.W., et al. The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity. Mol. Cell Biol. 28 (2008), 4829–4842.
48. 48 Gao, X., et al. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 45 (2012), 598–609.
49. 49 Jiang, Y., et al. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol. Cell 53 (2014), 75–87.
50. 50 Hosios, A.M., et al. Lack of evidence for PKM2 protein kinase activity. Mol. Cell 59 (2015), 850–857.
51. 51 Luo, W., et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145 (2011), 732–744.
52. 52 Wang, H.J., et al. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 279–284.
53. 53 Lee, J., et al. Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription. Int. J. Biochem. Cell Biol. 40 (2008), 1043–1054.
54. 54 Li, S., et al. Serine and SAM responsive complex SESAME regulates histone modification crosstalk by sensing cellular metabolism. Mol. Cell 60 (2015), 408–421.
55. 55 Zhong, X.H., Howard, B.D., Phosphotyrosine-containing lactate dehydrogenase is restricted to the nuclei of PC12 pheochromocytoma cells. Mol. Cell Biol. 10 (1990), 770–776.
56. 56 Grosse, F., et al. Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex. Eur. J. Biochem. 160 (1986), 459–467.
57. 57 Castonguay, Z., et al. Nuclear lactate dehydrogenase modulates histone modification in human hepatocytes. Biochem. Biophys. Res. Commun. 454 (2014), 172–177.
58. 58 McEwen, B.S., et al. Studies on energy-yielding reactions in thymus nuclei. II. Pathways of aerobic carbohydrate catabolism. J. Biol. Chem. 238 (1963), 2571–2578.
59. 59 De, P., Chatterjee, R., Nucleolar localization of succinic dehydrogenase in human malignant cells with MTT. Experientia, 18, 1962, 562.
60. 60 De, P., Chatterjee, R., Evidence of nucleolar succinic dehydrogenase activity. Exp. Cell Res. 27 (1962), 172–173.
61. 61 Yogev, O., et al. Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol., 8, 2010, e1000328.
62. 62 Jiang, Y., et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 17 (2015), 1158–1168.
63. 63 Lo, Y.W., et al. Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer. J. Cell. Mol. Med. 19 (2015), 744–759.
64. 64 Lee, S.M., et al. A nucleocytoplasmic malate dehydrogenase regulates p53 transcriptional activity in response to metabolic stress. Cell Death Differ. 16 (2009), 738–748.
65. 65 Jung, S.J., et al. Essential function of Aco2, a fusion protein of aconitase and mitochondrial ribosomal protein bL21, in mitochondrial translation in fission yeast. FEBS Lett. 589 (2015), 822–828.
66. 66 Haraguchi, C.M., et al. Localization of a mitochondrial type of NADP-dependent isocitrate dehydrogenase in kidney and heart of rat: an immunocytochemical and biochemical study. J. Histochem. Cytochem 51 (2003), 215–226.
67. 67 Agarwal, S., et al. Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing. Neuro Oncol 15 (2013), 718–726.
68. 68 Chen, Y., et al. Quantitative acetylome analysis reveals the roles of SIRT1 in regulating diverse substrates and cellular pathways. Mol. Cell. Proteomics 11 (2012), 1048–1062.
69. 69 Huang, H., et al. SnapShot: histone modifications. Cell, 159, 2014, 458.
70. 70 Wellen, K.E., et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009), 1076–1080.
71. 71 Madiraju, P., et al. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 4 (2009), 399–403.
72. 72 Xu, M., et al. An acetate switch regulates stress erythropoiesis. Nat. Med. 20 (2014), 1018–1026.
73. 73 Chueh, F.Y., et al. Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription. Cell. Signal. 23 (2011), 1170–1178.
74. 74 Latham, T., et al. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 40 (2012), 4794–4803.
75. 75 Shimazu, T., et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339 (2013), 211–214.
76. 76 Katoh, Y., et al. Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein. Mol. Cell 41 (2011), 554–566.
77. 77 Kera, Y., et al. Methionine adenosyltransferase II-dependent histone H3K9 methylation at the COX-2 gene locus. J. Biol. Chem. 288 (2013), 13592–13601.
78. 78 Chowdhury, R., et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep. 12 (2011), 463–469.
79. 79 Xiao, M., et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 26 (2012), 1326–1338.
80. 80 Xu, W., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19 (2011), 17–30.
81. 81 Klose, R.J., Zhang, Y., Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8 (2007), 307–318.
82. 82 Lu, C., Thompson, C.B., Metabolic regulation of epigenetics. Cell Metab. 16 (2012), 9–17.
83. 83 Wang, P., et al. Oncometabolite D-2-hydroxyglutarate inhibits ALKBH DNA repair enzymes and sensitizes IDH mutant cells to alkylating agents. Cell Rep. 13 (2015), 2353–2361.
84. 84 Cedar, H., Bergman, Y., Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10 (2009), 295–304.
85. 85 Choudhary, C., et al. The growing landscape of lysine acetylation links metabolism and cell signalling. Nat. Rev. Mol. Cell Biol. 15 (2014), 536–550.
86. 86 Cai, L., et al. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 42 (2011), 426–437.
87. 87 Shi, L., Tu, B.P., Acetyl-CoA induces transcription of the key G1 cyclin CLN3 to promote entry into the cell division cycle in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 7318–7323.
88. 88 Moussaieff, A., et al. Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab. 21 (2015), 392–402.
89. 89 Wang, J., et al. Dependence of mouse embryonic stem cells on threonine catabolism. Science 325 (2009), 435–439.
90. 90 Hardie, D.G., et al. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13 (2012), 251–262.
91. 91 Bungard, D., et al. Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science 329 (2010), 1201–1205.
92. 92 Berwick, D.C., et al. The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J. Biol. Chem. 277 (2002), 33895–33900.
93. 93 Potapova, I.A., et al. Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. Biochemistry 39 (2000), 1169–1179.
94. 94 Lee, J.V., et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20 (2014), 306–319.
95. 95 Cohen, H.Y., et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 305 (2004), 390–392.
96. 96 Newman, R.H., et al. Genetically encodable fluorescent biosensors for tracking signaling dynamics in living cells. Chem. Rev. 111 (2011), 3614–3666.
97. 97 Paige, J.S., et al. Fluorescence imaging of cellular metabolites with RNA. Science, 335, 2012, 1194.
98. 98 Paige, J.S., et al. RNA mimics of green fluorescent protein. Science 333 (2011), 642–646.
99. 99 Li, T., et al. Glyceraldehyde-3-phosphate dehydrogenase is activated by lysine 254 acetylation in response to glucose signal. J. Biol. Chem. 289 (2014), 3775–3785.
100. 100 Ventura, M., et al. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase is regulated by acetylation. Int. J. Biochem. Cell Biol. 42 (2010), 1672–1680.
101. 101 Lv, L., et al. Mitogenic and oncogenic stimulation of K433 acetylation promotes PKM2 protein kinase activity and nuclear localization. Mol. Cell 52 (2013), 340–352.
102. 102 Vervoorts, J., et al. Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4 (2003), 484–490.
103. 103 Faiola, F., et al. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription. Mol. Cell Biol. 25 (2005), 10220–10234.
104. 104 Patel, J.H., et al. The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol. Cell Biol. 24 (2004), 10826–10834.
105. 105 Yang, W., et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat. Cell Biol. 14 (2012), 1295–1304.
106. 106 Lindquist, S., The heat-shock response. Annu. Rev. Biochem. 55 (1986), 1151–1191.
107. 107 Stewart, M., Molecular mechanism of the nuclear protein import cycle. Nat. Rev. Mol. Cell Biol. 8 (2007), 195–208.
108. 108 Pelaez, R., et al. Nuclear import of the yeast hexokinase 2 protein requires alpha/beta-importin-dependent pathway. J. Biol. Chem. 287 (2012), 3518–3529.
109. 109 Neuspiel, M., et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr. Biol. 18 (2008), 102–108.
110. 110 Soubannier, V., et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr. Biol. 22 (2012), 135–141.
111. 111 Langley, O.K., Ghandour, M.S., An immunocytochemical investigation of non-neuronal enolase in cerebellum: a new astrocyte marker. Histochem. J. 13 (1981), 137–148.
112. 112 Losman, J.A., Kaelin, W.G. Jr, What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev. 27 (2013), 836–852.
113. 113 Killian, J.K., et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov. 3 (2013), 648–657.
114. 114 Liu, Z., et al. Inhibition of cancer-associated mutant isocitrate dehydrogenases: synthesis, structure–activity relationship, and selective antitumor activity. J. Med. Chem. 57 (2014), 8307–8318.
115. 115 DeLaBarre, B., et al. Action at a distance: allostery and the development of drugs to target cancer cell metabolism. Chem. Biol. 21 (2014), 1143–1161.
116. 116 Comerford, S.A., et al. Acetate dependence of tumors. Cell 159 (2014), 1591–1602.
117. 117 Srere, P.A., The citrate cleavage enzyme. I. Distribution and purification. J. Biol. Chem. 234 (1959), 2544–2547.
118. 118 Metallo, C.M., et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481 (2012), 380–384.
119. 119 Mullen, A.R., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481 (2012), 385–388.
120. 120 Madeo, F., et al. Caloric restriction mimetics: towards a molecular definition. Nat. Rev. Drug Discov. 13 (2014), 727–740.
121. 121 Hatzivassiliou, G., et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8 (2005), 311–321.
122. 122 Dambrova, M., et al. Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc. Med. 12 (2002), 275–279.
123. 123 Makrecka, M., et al. Mildronate, the inhibitor of L-carnitine transport, induces brain mitochondrial uncoupling and protects against anoxia-reoxygenation. Eur. J. Pharmacol. 723 (2014), 55–61.
124. 124 Zhu, Y., et al. Efficacy and safety of mildronate for acute ischemic stroke: a randomized, double-blind, active-controlled phase II multicenter trial. Clin. Drug Investig. 33 (2013), 755–760.
125. 125 Stein, E.M., et al. AG-221, an oral, selective, first-in-class, potent inhibitor of the IDH2 mutant metabolic enzyme, induces durable remissions in a Phase I study in patients with IDH2 mutation positive advanced hematologic malignancies. Blood, 124, 2014, 115.
126. 126 Doherty, J.R., Cleveland, J.L., Targeting lactate metabolism for cancer therapeutics. J. Clin. Invest. 123 (2013), 3685–3692.
127. + channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11 (2007), 37–51.
128. 128 Michelakis, E.D., et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med., 2, 2010, 31ra34.
129. 129 Chu, Q.S., et al. A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors. Invest. New Drugs 33 (2015), 603–610.
130. 130 Dunbar, E.M., et al. Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors. Invest. New Drugs 32 (2014), 452–464.
131. 131 Fan, J., et al. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect. J. Biol. Chem. 289 (2014), 26533–26541.
132. 132 Boxer, M.B., et al. Evaluation of substituted N,N’-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. J. Med. Chem. 53 (2010), 1048–1055.
133. 133 Jiang, J.K., et al. Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorg. Med. Chem. Lett. 20 (2010), 3387–3393.
134. 134 Anastasiou, D., et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8 (2012), 839–847.